METTL3 and osteoporosis: In a study by Wuet al. [197], animal experiments were conducted and confirmed that Mettl3 deficiency in bone marrow MSCs leads to osteoporosis, demonstrating to some extent the feasibility of targeting m6A to regulate bone formation-related cells for the treatment of osteoporosis.